Funded Tech Companies
Altheos
Altheos is a biopharmaceutical growth company, based in South San Francisco. Venture capital investment was provided by Novo Ventures, Bay City Capital and Canaan Partners.
Company Overview
Company Name
Altheos
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
601 Gateway Blvd. 250
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Altheos, Inc. is focused on the development of a best-in-class next-generation eye drop treatment for glaucoma. The lead compound, ATA907, is a selective rho-kinase (ROCK) inhibitor developed specifically for topical treatment of glaucoma which Altheos licensed from a Japanese pharmaceutical company.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/9/2012
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Henry Hsu
Chief Medical Officer
Barbara Wirostko
Chief Scientific Officer
Ken Kengatharan
VP - Product Management
Andrew Lam
Company Investors
- Novo Ventures (Peter Bisgaard)
- Bay City Capital (Lester Kaplan)
- Canaan Partners (Wene Hutton)
- Canaan Partners (Wende Hutton)
- Life Science Angels
Browse more funded tech companies:
AltheaDx | AltheRx Pharmaceuticals
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs